ir.genmarkdx.comInvestors Overview | GenMark Diagnostics, Inc.
ir.genmarkdx.com Profile
Ir.genmarkdx.com is a subdomain of genmarkdx.com, which was created on 2009-11-09,making it 15 years ago.
Description：The Investor Relations website contains information about GenMark Diagnostics, Inc. business for stockholders, potential investors, and financial...
Discover ir.genmarkdx.com website stats, rating, details and status online.Use our online tools to find owner and admin contact info. Find out where is server located.Read and write reviews or vote to improve it ranking. Check alliedvsaxis duplicates with related css, domain relations, most used words, social networks references. Go to regular site
ir.genmarkdx.com Information
| HomePage size: 89.413 KB |
| Page Load Time: 0.189533 Seconds |
| Website IP Address: 23.47.145.24 |
ir.genmarkdx.com Similar Website
| Aptiv PLC - Investor Information |
| Owens Corning Investors Overview |
| CI&T Investors Overview |
| Maryland Real Estate Investors Association - Maryland Real Estate Investors Association |
| Western Midstream - Investors - Investors |
| OMNOVA Solutions - Investors - Investors |
| Investors Overview | Tesla, Inc. |
| Investors | Marathon Oil Corporation - Investors |
| Pfizer Inc. - Investors Overview |
| Axalta Coating Systems - Investors - Investors Overview |
| Passage Bio, Inc. - Investors and News - Overview |
| Hyster-Yale Materials Handling, Inc., Investors - Investor Overview |
| Connected Investors | Connect With Real Estate Investors |
| Cornerstone OnDemand, Inc. - Investors - Overview |
| Investors - Toromont Industries Ltd. - Investors |
ir.genmarkdx.com PopUrls
https://ir.genmarkdx.com/ |
https://ir.genmarkdx.com/press-releases |
https://ir.genmarkdx.com/reports-and-filings |
https://ir.genmarkdx.com/news-releases/news-release-details/genmark-diagnostics-announces-commercial-launch-its-eplexr |
https://ir.genmarkdx.com/news-releases/news-release-details/genmark-diagnostics-eplexr-respiratory-pathogen-panel-2-rp2 |
https://ir.genmarkdx.com/news-releases/news-release-details/genmark-diagnostics-eplexr-respiratory-pathogen-panel-2-rp2-0 |
https://ir.genmarkdx.com/news-releases/news-release-details/genmark-diagnostics-announces-scott-mendel-appointed-ceo |
https://ir.genmarkdx.com/news-releases/news-release-details/roche-signs-definitive-merger-agreement-genmark-diagnostics-inc |
https://ir.genmarkdx.com/news-releases/news-release-details/genmark-receives-fda-emergency-use-authorization-its-eplexr-sars |
https://ir.genmarkdx.com/sec-filings/sec-filing/10-k/0001487371-20-000085 |
https://ir.genmarkdx.com/stock-information/analyst-coverage |
https://ir.genmarkdx.com/corporate-governance |
https://ir.genmarkdx.com/news-releases/news-release-details/genmark-diagnostics-report-fourth-quarter-and-full-year-2020 |
https://ir.genmarkdx.com/news-releases/news-release-details/genmark-diagnostics-provides-preliminary-operational-and-2 |
https://ir.genmarkdx.com/unsubscribe |
https://ir.genmarkdx.com/email-alerts |
https://ir.genmarkdx.com/news-releases/news-release-details/genmark-achieves-ce-mark-its-eplexr-blood-culture-0 |
https://ir.genmarkdx.com/news-releases/news-release-details/genmark-receives-fda-510k-market-clearance-its-eplexr-instrument |
https://ir.genmarkdx.com/news-releases/news-release-details/genmark-diagnostics-reports-first-quarter-2020-results |
https://ir.genmarkdx.com/sec-filings/sec-filing/sc-c/0001193125-21-084171 |
https://ir.genmarkdx.com/news-releases/news-release-details/genmark-announces-pricing-its-initial-public-offering |
https://ir.genmarkdx.com/news-releases/news-release-details/genmark-diagnostics-participate-jp-morgan-healthcare-conference |
ir.genmarkdx.com Httpheader
| Accept-Ranges: bytes |
| Content-Encoding: gzip |
| Content-Language: en |
| Content-Type: text/html; charset=UTF-8 |
| device: desktop |
| ETag: "1620697881" |
| Expect-CT: max-age=0, report-uri="/report-expect-ct-violation" |
| Feature-Policy: "accelerometer none;ambient-light-sensor none;autoplay self;camera none;encrypted-media none;fullscreen self;geolocation self;gyroscope none;magnetometer none;microphone none;midi none;payment none;picture-in-picture none;speaker self;sync-xhr self;usb none;vibrate none;vr none", From-Origin: same |
| Last-Modified: Tue, 11 May 2021 01:51:21 GMT |
| Link: http://ir.genmarkdx.com/; rel="shortlink", http://ir.genmarkdx.com/; rel="canonical", https://ir.genmarkdx.com/investor-relations; rel="alternate"; hreflang="en", https://ir.genmarkdx.com/investor-relations; rel="revision" |
| Referrer-Policy: no-referrer-when-downgrade |
| X-Age: 2322 |
| X-Cache-Hits: 1 |
| X-Content-Type-Options: nosniff |
| X-Drupal-Dynamic-Cache: UNCACHEABLE |
| X-Frame-Options: SAMEORIGIN |
| X-Request-ID: v-626ddc68-b1fb-11eb-a820-1788c7618942 |
| X-UA-Compatible: IE=edge |
| X-XSS-Protection: 1; mode=block |
| Content-Length: 13976 |
| X-EdgeConnect-MidMile-RTT: 13, 13 |
| X-EdgeConnect-Origin-MEX-Latency: 9, 9 |
| Cache-Control: public, max-age=0, s-maxage=2700 |
| Expires: Tue, 11 May 2021 02:30:05 GMT |
| Date: Tue, 11 May 2021 02:30:05 GMT |
| Connection: keep-alive |
| Vary: Accept-Encoding |
| Set-Cookie: DrupalVisitorMobile=0; path=/; Secure; HttpOnly |
| Strict-Transport-Security: max-age=15768000 ; preload |
ir.genmarkdx.com Meta Info
| charset="utf-8"/ |
| content="GenMark Diagnostics, Inc." property="og:site_name"/ |
| content="website" property="og:type"/ |
| content="The Investor Relations website contains information about GenMark Diagnostics, Inc. business for stockholders, potential investors, and financial analysts." name="description"/ |
| content="no-referrer" name="referrer"/ |
| content="Drupal 8 (https://www.drupal.org)" name="Generator"/ |
| content="width" name="MobileOptimized"/ |
| content="true" name="HandheldFriendly"/ |
| content="width=device-width, initial-scale=1.0" name="viewport"/ |
ir.genmarkdx.com Ip Information
| Ip Country: United States |
| City Name: Secaucus |
| Latitude: 40.7876 |
| Longitude: -74.06 |
ir.genmarkdx.com Html To Plain Text
Top Nav Panels ePlex Panels Respiratory Blood Culture XT-8 Panels Systems ePlex System Software Solutions Patient Safety XT-8 System Company The GenMark Story Management Team Board of Directors Careers Opportunities Investors Newsroom Education Disease State Sepsis Respiratory Infections Genetic Conditions Hepatitis C GI Infections Technology Resources Support Contact Us FAQs Safety Data Sheets (SDS) Your Long-Term Partner CONTACT US | CUSTOMER RESOURCE CENTER Top Nav Panels ePlex Panels Respiratory Blood Culture XT-8 Panels Systems ePlex System Software Solutions Patient Safety XT-8 System Company The GenMark Story Management Team Board of Directors Careers Opportunities Investors Newsroom Education Disease State Sepsis Respiratory Infections Genetic Conditions Hepatitis C GI Infections Technology Resources Support Contact Us FAQs Safety Data Sheets (SDS) Your Long-Term Partner Investors Investor Relations Stock Information Stock Quote & Chart Historic Stock Lookup Analyst Coverage SEC Filings Press Releases Events & Presentations Corporate Governance Email Alerts Investors Overview GenMark Diagnostics is a leading provider of multiplex molecular diagnostic solutions designed to enhance patient care, improve key quality metrics, and reduce the total cost-of-care. Utilizing GenMark’s proprietary eSensor ® detection technology, GenMark’s eSensor XT-8 ® and ePlex ® systems are designed to support a broad range of molecular diagnostic tests with compact, easy-to-use workstations and self-contained, disposable test cartridges. GenMark’s ePlex: The True Sample-to-Answer Solution ® is designed to optimize laboratory efficiency and address a broad range of infectious disease testing needs, including respiratory, bloodstream, and gastrointestinal infections. GenMark Diagnostics () Today’s Open Previous Close Volume Exchange Today’s High Today’s Low 52 Week High 52 Week Low Data Provided by Refinitiv. Minimum 15 minutes delayed. lnk Stock Information View More Stock Information lnk FAQs FAQs Reports and Filings May 4, 2020 2020 Proxy Statement 2.4 MB May 4, 2020 2019 Annual Report 1.6 MB lnk Reports & Filings View More Press Releases March 15, 2021 Roche signs definitive merger agreement with GenMark Diagnostics, Inc., to access novel technology to test for broad range of pathogens with one patient sample February 25, 2021 GenMark Diagnostics Reports Fourth Quarter and Full Year 2020 Results February 22, 2021 GenMark ePlex® RP2 Panel Predicted to Detect Known SARS-CoV-2 Variants Currently in Circulation Based on in silico Analysis lnk News View More Presentations January 12, 2021 GNMK January 2021 Investor Presentation 2.6 MB lnk Presentation View More Events March 1, 2021 at 2:00 PM EST Cowen 41st Annual Health Care Conference Listen to webcast lnk Events View More Corporate Governance August 2, 2019 Audit Committee Charter 255.1 KB February 15, 2013 Insider Trading Policy 135 KB lnk Corporate Governance View More Email Alerts Automatically receive GenMark Dx financial information by email. lnk Email Alert Learn More GenMark Diagnostics, Inc. 5964 La Place Court Carlsbad, CA 92008 © Copyright 2021 GenMark Diagnostics, Inc. All rights reserved. info@genmarkdx.com P: +1 760-448-4300 F: +1 760-448-4301 Footer Links Legal | Privacy Policy...
ir.genmarkdx.com Whois
Domain Name: GENMARKDX.COM Registry Domain ID: 1575120676_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.safenames.net Registrar URL: http://www.safenames.net Updated Date: 2023-10-17T06:52:05Z Creation Date: 2009-11-09T18:00:13Z Registry Expiry Date: 2025-11-09T18:00:13Z Registrar: SafeNames Ltd. Registrar IANA ID: 447 Registrar Abuse Contact Email: abuse@safenames.net Registrar Abuse Contact Phone: +44.1908200022 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: BUCK.NS.CLOUDFLARE.COM Name Server: PHOENIX.NS.CLOUDFLARE.COM DNSSEC: unsigned >>> Last update of whois database: 2024-05-17T21:21:37Z <<<